drugset / Trial / NCT02905695
Post-partum Perineal Pain - Chirocaine®
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this placebo-controlled clinical trial is to assess the effectiveness of the local infiltration of the analgesic Chirocaïne® on perineal pain after episiotomy or first-degree tear. The pain intensity is measured in immediate postpartum period by using a numerical rating scale (NRS) at the following times: H2, H4, H8, H12, H24, H36, H48 during rest, defecation and during activities. The safety of Chirocaïne® and the patient satisfaction are also evaluated at each time.
Timeline
- Start
- 2011-01
- Primary completion
- 2015-01
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levobupivacaine | Other / unclassified | — | Other |
Indications
No indication recorded.